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The multidisciplinary team (MDT) approach illustrates how motor classification systems,
assessments and outcome measures currently available have been applied to a national
cohort of children and young people with dystonia and other hyperkinetic movement dis-
orders (HMD) particularly with a focus on dyskinetic cerebral palsy (CP). The paper is divided
in 3 sections. Firstly, we describe the service model adopted by the Complex Motor Disorders
Service (CMDS) at Evelina London Children's Hospital and King's College Hospital (ELCH-
KCH) for deep brain stimulation. We describe lessons learnt from available dystonia studies
and discuss/propose ways to measure DBS and other dystonia-related intervention out-
comes. We aim to report on current available functional outcome measures as well as some
impairment-based assessments that can encourage and generate discussion among move-
ment disorders specialists of different backgrounds regarding choice of the most important
areas to be measured after DBS and other interventions for dystonia management. Finally,
some recommendations for multi-centre collaboration in regards to functional clinical
outcomes and research methodologies for dystonia-related interventions are proposed.
Crown Copyright © 2016 Published by Elsevier Ltd on behalf of European Paediatric
Neurology Society. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Background
Objective measurement across all domains of the Interna-
tional Classification of Functioning (ICF), Disability andorders Service, 6th Floor,
1 7EH, UK.
.nhs.uk, ht.gimeno@gma
by Elsevier Ltd on behal
://creativecommons.org/Health1 has been recommended as an essential element in
rehabilitation.2e4 These include i) body function and struc-
tures, ii) activity and iii) participation. Whilst body function
and structures focuses on impairments, activity andEvelina Children's Hospital, Guy's & St Thomas' NHS Foundation
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limitations and restrictions. This framework has been widely
adopted to define and measure health and disability. It pro-
vides common terminology for professionals internationally
and from different backgrounds. The focus is on the child and
the interaction with two other key domains of the ICF, i) the
environment taking into account impairments but also ii)
contextual factors such as personal ones. The evaluation of
the different dimensions across the ICF allows better repre-
sentation of the child's needs, strengths and living experience
with dystonia with emphasis on family-centred care, the use
of functional outcomemeasures, andmeasuring how children
and young people with disabilities can live meaningful lives.
Despite 15 years since the ICF framework was published,
much of the current research in childhood dystonia and other
hyperkinetic movement disorders (HMD) has concentrated on
genetic diagnoses and other aetiologies. The interventional
studies available in childhood dystonia and other HMD focus
in the majority on outcomes within the impairment level
without attempting to elaborate on what this might mean at
the levels of activity and participation.5 A recent Lancet review
by Koy et al. (2016)6 on the management of movement disor-
ders in children outlines a number of recommendations
including better trials of interventions, preferably disease-
modifying, optimized for different age groups of children
and using appropriate assessment scales that can be univer-
sally employed across all childhood dystonias from isolated
monogenetic, acquired brain injury to heredodegenerative
and neurometabolic causes of childhood dystonia.
Childhood dystonia and other hyperkinetic movement
disorders (HMD) are a heterogeneous group in terms of aeti-
ology, motor severity, functional abilities, motor and non-
motor co-morbidities. Dystonia is a neurological syndrome
characterised by involuntary, patterned, sustained, or repeti-
tive muscle contractions of opposing muscles, resulting in
abnormal twisting bodymovements and abnormal postures7,8
which can also be tremulous. Dystonia affects adults and
children and is one of themost disablingmovement disorders,
both for the individual and their families. The causes and
clinical presentations of dystonia are heterogeneous, and
dystonia has mostly been classified by aetiology within two
broad categories:
i. Primary dystonias have no structural brain abnormality
and often no known underlying cause, although genetic
mutations are being increasingly identified e.g. DYT1;
DYT6; DYT11 and many others though genetic heteroge-
neity and phenotypic pleiotropy is also increasingly
recognised.9
ii. Secondary dystonias, including Cerebral Palsy10 in which
structural abnormalities of the brain are usually visible
arising from perinatal injuries such as periventricular
leukomalacia (PVL), hypoxic-ischaemic encephalopathy
(HIE), kernicterus, localised strokes of the basal ganglia,
cortical and subcortical malformations including hypo-
and dys-myelinating disorders and an extremely wide
range of individually rare but collectively important neu-
rometabolic disorders as well as neurodegenerative
disorders such as Neurodegeneration with Brain Iron
Accumulation (NBIA).6,7,11,12More recently, Albanese and colleagues8 have proposed a
new classification based on two axes:
Axis 1: Age at onset, body distribution, temporal pattern
and associated features (additional movement disorders or
neurological features).
Axis 2: Aetiology, which includes nervous system pathol-
ogy and inheritance, to “provide meaningful information
on any dystonia patient and serve as a basis for the
development of research and treatment strategies”.
This classification could be useful in very large cohorts of
patients such as an international database for example as
launched byMarks and colleagues (2016).13 The grouping of all
variables into pragmatic, yet clinically appropriate, subgroups
might be needed in order to make clinical sense of results
across different groups of patients. We have briefly reported14
the newly proposed classification system to a sample of 145
children and young people presenting with dystonia to a ter-
tiary centre however the application of the classification sys-
tem resulted in 4 major sub-groups: 1) primary dystonia, ii)
primary plus dystonia, iii) secondary static dystonia and iv)
heredodegenerative conditions.
Deep brain stimulation (DBS) of the Globus Pallidus has
now been established as an effective intervention for primary
dystonia, in both controlled15 and open label studies16 as well
as long term studies17 and for a general review of DBS in
children see Lin 2016.18e20 In addition, the UK's National
Institute for Health and Clinical Excellence (NICE) have
approved DBS for parkinsonism (although Parkinsonism is
rare in children), dystonia and tremor movement disorders in
adults and children and have also provided guidelines sup-
porting the use of DBS as a safe and efficacious procedure for
dystonia and tremor.21 Despite these well conceived and
described studies, the functional status and recovery of even
primary dystonias following DBS has not yet been well-
described and young people continue to face significant
functional difficulties despite an impressive motor recovery
fromdystonia impairment, indicating that primary dystonia is
a disorder affecting motor function beyond motor skills
alone.22 Non-motor symptoms have been described in pri-
mary dystonia in the adult population23e26 but reports in
paediatrics are lacking and more research in this area is
needed.
There are known to be around 70,000 sufferers of dystonia
in the UK alone.27 Although there is evidence of a falling
prevalence of CP arising from moderately low birth-weight
(MLBW) and very low birth-weight (VLBW) in Europe for the
period 1980e2003 with an overall fall in prevalence from 1.9 to
1.77/1000 live births. The prevalence of CP in normal birth-
weight (NBW) babies (i.e. the majority of cases) and
extremely low birth-weight infants remain unchanged. Also,
the prevalence of dyskinetic (dystonic-choreoathetosis) CP
has remained unchanged at 3.5, 4.3 and 4e8% for ELBW, VLBW
and MLBW babies respectively and 10.8% for NBW babies.28
There is also an increasing acceptance that dyskinetic CP
is under-recognised in the CP population in general due to
lack of appropriate operational definitions of clinical phe-
nomenology with evident consequences for appropriate
management.10,29,30 The use of the hypertonus assessment
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spasticity.31
Limitations of the standard pharmacological and thera-
peutic interventions for the management of both primary and
secondary childhood dystonias6,32 and inexorable progression
to functional musculoskeletal deformity within the first 5e10
years of life33 have therefore resulted in an increasing demand
for alternative neuromodulation techniques, such as DBS.6
Specific studies solely related to the evaluation of out-
comes following DBS in childhood dystonia are still limited,
particularly as only outcomes on reduction of dystonia are
often shared5 and functional recovery is not well described in
the literature.34
The heterogeneity of this group of conditions makes it
difficult to systematically approach measurement across the
domains of the ICF, particularly at the level of activity and
participation and it requires a multidisciplinary approach
including AHPs as part of the core team managing children
and young people with dystonia and other HMD. Perhaps this
is one of the reasons why research reports regarding func-
tional difficulties and outcomes following interventions are
lacking. Even when clinical and objective measures are
advocated, scales of dystonia severity alone persist as the sole
outcome measure35 while emphasising that the main goal of
rehabilitation is to improve function and reduction of dysto-
nia severity alone may not necessarily result in a change in
function. It is therefore critical to review available and valid
functional outcome measures on dystonia. The use of
outcome measures in childhood dystonia will be addressed
later.
The multidisciplinary team (MDT) approach illustrates
how motor classification systems, assessments and outcome
measures currently available have been applied to a cohort of
children and young people with dystonia and other HMD
particularly with a focus on cerebral palsy (CP). We aim to
report on current available functional outcome measures as
well as some impairment-based assessments that can
encourage and generate discussion among movement disor-
ders specialists of different backgrounds regarding choosing
the most important areas to be measured after DBS and other
interventions for dystonia management.
Specific aims of this paper are:
(1) To describe the Evelina London Children's Hospital &
King's College Hospital (ELCH-KCH) DBS service model
and explain the process of creating a ‘Minimal-accept-
able-best practice’ model
(2) To describe what we have learnt from dystonia studies
and discuss ways to measure DBS outcomes and effects
of other interventions for dystonia including the chal-
lenges faced in measuring outcomes;
(3) To suggest recommendations for multi-centre collabo-
ration regarding functional clinical outcomes and
researchmethodologies for interventions with dystonia
1 The Complex Motor Disorders Service (CMDS) service
model
The ELCH-KCH DBS service is client-focused and bench-
marked to ‘best practice’ criteria as proposed by the WorldHealth Organisation's International Classification of Function
(ICF).1 Moving away from impairment-based models of prac-
tice, the ICF focuses on activity and participation. This philos-
ophy forms the basis of our multidisciplinary client-centred
service model. Fig. 1 shows areas of assessment and inter-
vention in our service model.1.1. How the Evelina London Children's Hospital-King's
College Hospital DBS service began
The Evelina DBS service was originally created in 2005 after
some inspirational work with the Montpellier DBS group. In
2003 and 2004, two children with extremely severe primary
idiopathic torsion dystonia (DYT1-positive) were sent from
London to Professor Philippe Coubes, neurosurgeon in Mont-
pellier, France. These children were both implanted with
bilateral Globus Pallidus Internus (GPi) deep brain stimulators,
which resulted in a marked reduction in their dystonia.
The paediatric Complex Motor Disorders Service (CMDS)
began in May 2005 with the first bilateral Globus Pallidus
Internus (GPi) Deep brain stimulation (DBS) implant in a four
year-old boy with dystonia secondary to a rapidly progressive
neurodegenerative disorder. The functional neurosurgery was
performed at King's College Hospital by Mr. Richard Selway,
Consultant Functional Neurosurgeon as a joint Guy's & St
Thomas' & King's College Hospital collaboration. The appro-
priateness of DBS in 5 clinically selected children with severe
dystonia was discussed with Professor Phillipe Coubes and Dr
Laura Cif who visited our unit and advised on clinical issues.
These children then became the service's first DBS cases and
lead to the successful funding application for a dedicated
multidisciplinary ComplexMotor Disorders Service (CMDS) by
the Guy's and St Thomas' Charity which began recruiting team
members of the CMDS at Evelina London Children's Hospital
(ELCH) in April 2007. As with all new services, we have
received referrals for young people with extreme dystonia at
the young adult age-range reflecting the spectrum of unmet
need in this field of neurology.
The first stage involved defining a multidisciplinary client-
focused CMDS for assessment and management of children
and young people undergoing DBS. At this stage, various fac-
tors were considered, including listening to the views of
children and families being treated, as well as careful
consideration of governmental and societal guidelines and
recommendations, all of which highlight the need for multi-
disciplinary team input. These included:
- The National Service Framework (NSF) for Children and
Young People,53 whose recommendations include (i)
listening to families' feedback in development of services;
(ii) promoting social inclusion of children with disabilities
and facilitation of improved function and participation in
daily life; and (iii) supporting an MDT approach so that
services can effectively co-ordinate around the needs of
the child and family
- NICE guidelines for ‘DBS for tremor and dystonia
(excluding Parkinson's disease)’,21 which recommend that
DBS intervention and care “… should be carried out in the
context of a multidisciplinary team …”
Fig. 1 e ICF areas addressed by the MDT in CMDS. This figure illustrates the multi-dimensional approach to assessment
with examples of some of what outcomemeasures could be utilised. Not all assessments are completed with all children, as
this would depend on their level of motor severity and manual function ability as well as cognitive ability. Abbreviations:
MRI: Magnetic Resonance Imaging; PET: Positron Emission Tomography; CMCT: Central Motor Conduction Time; SSEP:
Somato-Sensory Evoked Potentials; BFMDRS: Burke-Fahn-Marsden Dystonia Rating Scale36; GMFM: Gross Motor Function
Measure37; MA-2: Melbourne Assessment e 238; BOT-2: BruininkseOseretsky Test Of Motor Proficiency (REF); BADS-C:
Behavioural assessment of dysexecutive syndrome39; NEPSY: Developmental NEuroPSYchological Assessment40; D-KEFS:
Delis-Kaplan Executive Function Syndrome41; WISC: Wecshler Intelligence Scale for Children42; CMS: Children's Memory
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assessment process for DBS and regular follow-ups to
ensure maximum clinical efficiency.27
The subsequent NHS approval of DBS for movement dis-
orders (April 2013) with guidance notes was not then
available.54
1.2. Essential components to our assessment and
management service model
The CMDS team at ELCH-KCH consists of a bespoke multi-
disciplinary team including neurologists, neurosurgeons, a
specialist nurse, psychologist, physiotherapist, occupational
therapist, speech and language therapist and a therapy as-
sistant crucial to the delivery of a large ‘battery’ of tests and
assessments, video archiving, and consents for assessments
working in a trans-disciplinary model of practice to meet the
needs of the child.55 One of our main aims has been to move
away froma puremedical-surgicalmodel but rather to adopt a
family-centred approach reflecting the importance of collab-
orative partnerships with families, clients and others working
with the child.
Recently, there has been a shift away from approaches
aimed at “fixing” the child/young person, instead, the focus is
on activity and participation underpinned by the International
Classification of Functioning (ICF). This shift has been driven
by factors such as our changing understanding of child
development, emphasis on family-centred care, use of func-
tional outcome measures and determining what is important
for young people with disabilities to live meaningful lives.
This fosters the children's sense of own competency and en-
ables the young person and their family to address factors that
also impact on the child's ability “to do”. In short, supporting
young people and their families in becoming experts on
managing their own condition.
Our assessment process includes a repertoire of imaging
and medical testing but goes beyond the impairment level (as
outlined in the WHO ICF framework) and also assesses other
areas that would affect the child/young person's ability to
participate fully in all activities of daily living in the commu-
nity, albeit within a hospital context.
This multi-disciplinary service has been established to
assess the suitability of children with complex motor disor-
ders for specialised neurosurgical interventions such as
intrathecal baclofen (ITB) pump implantation for mixed
spasticity and dystonia or deep brain stimulation (DBS) for
dystonia alone. A number of patients are additionally referred
for diagnostic and management support. Patients are referred
from all over the United Kingdom and Ireland for DBS and
more regionally for ITB. A number of international referrals
are received, predominantly for DBS. Fig. 2 represents an
outline of the assessment process.Scale43; PPI: Paediatric Pain Profile44; AMPS: Assessment of Mot
Scale46; TUG: Time-up and go47; DASH: Detailed Assessment of
Disability Inventory e Computer Adaptive Test49; CPCHILD: Car
Disabilities50; COPM: Canadian Occupational Performance Meas
Classification of Functioning (1); MDT: Multidisciplinary team; C1.3. The patient journey
The bespoke multidisciplinary nature of the CMDS is reflected
in the patient's journey; from the initial stages of data gath-
ering prior to meeting the child and family, to the final dis-
cussions, goal-setting and decision-making for DBS or further
management options. The patient journey involves three
phases, which are represented in Fig. 3a and b.
Phase 1: Comprises a full MDT assessment including
neuro-radiological and neuro-physiology testing, functional
assessments led by allied health professionals (AHP) and a
range of impairment-based assessments, quality of life and
goal setting.
Phase I can commence (most likely) with a screening clinic
run by a consultant neurologist from CMDS and a senior AHP
(either physiotherapist or occupational therapist). A whole
week assessment might be preferable for those cases who are
rapidly deteriorating or living geographically far from the
South East of England. Bearing in mind the capacity of the
child and families to endure a whole week of assessments
including neuroimaging, neurophysiology and AHP assess-
ments detailed below. This might be further compounded by
environmental factors such as bed availability. Before chil-
dren and families attend their initial appointment a ques-
tionnaire is sent which allows gathering of preliminary
information about functional concerns and opening a dia-
loguewith family and child/young person. The questionnaires
(devised by HG with contributions from other teammembers)
consist of two versions based on the GFMCS severity levels
(one questionnaire for GFMCS levels IeIII and the other
questionnaire for GFMCS levels IV and V) (These are included
here as Supplementary Information e Supplementary Files 1
and 2). The questionnaires guide clinicians at initial
screening regarding appropriate assessments. The family
concerns are paramount and are the focus of much of this
initial discussion.
The detailed standardised assessments will depend on the
functional ability of the young person but as a rule of thumb,
the greater the functional ability, the more assessments it will
be theoretically possible to complete: the main purpose is to
obtain reliable and generalizable measures of function and
not be pegged by test-limited ceiling effects. The assessments
illustrated in Fig. 1 encompass assessments for all GMFCS
levels but not all will be performed with all the children and
young people. On Supplementary Information (Appendices 3
and 4) we have outlined the assessments that are routinely
completed by the MDT in all phases of the patient's journey.
The steps in phase one are aimed narrowly at confirming
suitability for neuromodulation andmore broadly at mapping
the underlying functional residual capacity of the child. This is
set against what we know about the natural history of dys-
tonia in childhood in all the known aetiological categories: i.e.
dystonia tends to worsen in 2/3 of cases or stay as bad in aor and Process Skills45; PQRS: Performance Quality Rating
Speed Handwriting48 PEDI-CAT: Pediatric Evaluation
egiver Priorities and Child Health Index of Live with
ure51; GAS: Goal Attainment Scale52; ICF: International
MDS: Complex Motor Disorders Service.
Fig. 2 e Assessment process outline. This figure represents the multi-dimensional approach to assessment before a
neurosurgical intervention such as deep brain stimulation (DBS) or intrathecal baclofen pump (ITB). The complexity of this
model requires the integration and collaboration of a multidisciplinary team. Abbreviations: MRI: Magnetic Resonance
Imaging, PET: Positron Emission Tomography, CMCT: Central Motor Conduction Time, SSEP: Somato-Sensory Evoked
Potentials, AMPS: Assessment of Motor and Process Skills, PQRS: Performance Quality Rating Scale, MA-2: Melbourne
Assessment e 2, GMFM: Gross Motor Function Measure, TUG: Time-up and go, QoL: Quality of Life, BFMDRS: Burke-Fahn-
Marsden Dystonia Rating Scale, COPM: Canadian Occupational Performance Measure, GAS: Goal Attainment Scale.
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in secondary dystonias around the age of 5 years and then
affect 80% of children by age 15 years33; adverse drug reactions
to commonly used antidystonic medication are common.32
This background information helps families contextualise
their child's dystonia preparatory to opting for neuro-
modulation intervention. The choice of goals clearly reflects a
combination of the developmental progress of the child and
motor severity across thewhole spectrum ofmotor ability and
dystonia severity. One way to describe the aim of neuro-
modulation is to expand the functional residual capacity of the
child. This is related to but different from reducing dystonia,
because the functional residual capacity is activity-related. An
often understated aim of the baseline assessment is to help
parents, carers and the MDT understand what matters most
to the child and demonstrate to families the border-zone be-
tween successful and unsuccessful activity as well as those
functions which are completely impossible. Goal-setting is
explored from the border-zone of function, brought out during
the assessment and is therefore clearly applicable to each
individual child or young person.
1.4. Meeting the neurosurgeon and concluding Phase I
The formal surgical information and discussion meeting is a
crucial multidisciplinary team event during which every
aspect of the child's case is reviewed, culminating in a reviewof the imaging, the neurophysiology, theMDT assessment and
goals. The purpose here is to review what has already been
discussed and allow the neurosurgeon to understand the
parent/carer/child perspective(s) in relation to risk and
benefit. Surgical risks, including risk of intra-cerebral bleeding
leading to possible stroke or fatality (<1% across the litera-
ture), device infection, disappointment at lack of efficacy, and
a variety of technical complications are reviewed based on
published reports as well as our ELCH-KCH data. However we
have been able to describe a much lower overall and specific
complication rate in our large cohort of children than previ-
ously published in smaller cases series, including previously
unpublished data for DBS in under 7-year-olds.56 Service-
specific risk data is particularly difficult to achieve at the
beginning of a service when limited team experience and the
absence of a track-record necessitate reliance on published
case-series. Broader information spanning all continents may
soon be available through the auspices of a international
paediatric DBS registry (PediDBS),13 aimed at collecting world-
wide experience of childhood DBS.
Another important way of helping with decision-making is
for families and children to meet others who have been
through the service already. Matching by age, aetiology and
severity of dystonia is important. Meeting someone after
recent DBS and also years later are important contrasting
experiences. It is important for these meetings to be inde-
pendent of the treating MDT. This is often also supplemented
Fig. 3 e a: Patient journeyover1weekadmission for assessment anddecision treeand followupprocess.Thisfigure represents
the multi-dimensional approach to assessment before a neurosurgical intervention such as deep brain stimulation (DBS) or
intrathecal baclofen pump (ITB) and the decision tree with different phases of assessment, implementation and review.
Abbreviations: GA MRI: General Anaesthesia Magnetic Resonance Imaging, GA FDG-PET-CT: General anaesthesia F-
Fluorodeoxyglucose Positron Emission Tomography-computed tomographic, CMCT: Central Motor Conduction Time, SSEP:
Somato-Sensory Evoked Potentials, KCH: King's College Hospital, DBS: Deep brain stimulation, ITB: Intrathecal Baclofen, MDT:
multidisciplinary team. b. CMDSprocess over separate hospital visits for assessment and decision tree. Abbreviations: GAMRI:
General Anaesthesia Magnetic Resonance Imaging, GA FDG-PET-CT: General anaesthesia F-Fluorodeoxyglucose Positron
Emission Tomography-computed tomographic, CMCT: Central Motor Conduction Time, SSEP: Somato-Sensory Evoked
Potentials, KCH: King's College Hospital, DBS: Deep brain stimulation, ITB: Intrathecal Baclofen, MDT: multidisciplinary team.
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Fig. 3 e (continued).
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facebook.com/DystoniaSociety/posts/229880783722051) and
advice from the Dystonia Society UK website, including the
guide to good clinical practice.27
A new and important source of information has been our
work with parents undertaking this complex decision-mak-
ing57 and the work of John Gardner, exploring DBS neuro-
modulation in children from a social sciences perspective
which depicts the implementation of the ‘Broad Clinical Gaze’
as a means of defining what is in the child's best interests
based on promoting activity and participation.58,59 As we have
discovered, despite categorising our children with dystonia
into the aetiological categories of primary or secondary, the
actual efficacy of DBS for each specific child remains uncer-
tain, in part because wide variations in responsiveness within
each aetiological grouping is possible. Bridging the gap be-
tween published cohort and specific patient outcomes re-
quires clinical experience and patience and the need toexplicitly discuss ‘disappointment’ as a possible complication
of DBS surgery. Further detailed information on how DBS
works has been recently reviewed.6,18,19,60,61 Overall, honesty
and candour still remain the best tools in the toolbox when
facing these issues with the family together with the
neurosurgeon.
Phase 2 includes the DBS surgery and peri-operative care.
Our neurosurgical practice has been previously described
in detail62e65 and with a few exceptions involves bilateral in-
frame stereotactic targeting of the postero-infero-
ventrolateral globus pallidus internus under inhaled iso-
fluorane general anaesthesia preceded by a once-a-day Octe-
nasen total body head-toe shampoo for 5 days before DBS and
5 days of perioperative cefuroxime iv antibiotics TDS for
prophylactic infection reduction beginning with induction of
anaesthesia at the start of DBS surgery. A single pass micro-
electrode recording is used to assess the ideal depth of the
stimulating intracerebral electrode.62 Planned recovery from
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for up to 24 h post-operatively together with Ondansetron
anti-emetic 8-hourly i. v. until nausea subsides. All regular
anti-dystonia medication is usually restored on waking up
from anaesthesia.
Phase 3 involves post-operative multidisciplinary reviews
at regular intervals of 1, 2, 3, 6, 9, 12 months and 6 monthly
thereafter, both to monitor outcome and progress and for the
MDT towork collaboratively with the family in order to ensure
good neurostimulator recharging routines and maximise the
effects of DBS on the young person's functioning and partici-
pation in daily life. Usually, a BFMDRS test is performed at
each visit along with a Timed Up and Go test (TUG) and 6-min
walk, when appropriate. The majority of functional outcome
measures take place are at 1, 2 and 5 years post DBS, though
annual full MDT assessments would be the ideal to capture
waxing and waning efficacy of DBS across the group, partic-
ularly in the light of recent information describing apparently
on-going improvements in dystonia for each year of neuro-
modulation66 rather than outcome saturation after the first
year of DBS. Reviews are repeated sooner if clinically
indicated.2. What we have learnt from dystonia
studies. An outline of functional clinical
outcomes proposed (and open for discussion)
A recent scoping review on the pharmacological and neuro-
surgical interventions available for dystonia and other HMD
revealed 72 management strategies (include anticholinergic
medication) all failed to address what mattered most to chil-
dren and young people. For the majority of the interventional
studies, the primary outcome measure was an impairment
measure,5 most often, the Burke-Fahn-Marsden Dystonia
Rating Scale (BFMDRS)67 though Liow et al., 2016, using the
ICF-framework of functions and Dystonia Severity Assess-
ment Plan (DSAP) have shown that dystoniamay respondwell
to Gabapentin68 particularly if associated with pain, difficulty
tolerating seating and poor sleep.
More recently Koy et al. 20166 reviewed ‘advances in the
management of movement disorders in children’ and it has
been concluded that therapeutic options for children with
dystonia remain an unmet need.
A systematic review69 on interventions for cerebral palsy
(CP) only provided evidence of interventions for spastic CP
without specific reference to dyskinetic CP. To date, no studies
exist of non-medical/non-surgical interventions based on
activity and participation in childrenwith dyskinetic CP or any
other HMD or even of specific sub-analysis of dyskinetic CP
results within studies that might have included a few cases
within larger spastic CP cohorts. Therefore generalisations of
results in this population should be taken with caution.
In this section we outline some key messages from the
different studies currently available. This section is divided
into different ICF domains:
i) At the level of impairment. We particularly focus on
assessment of dystonia severity, gross motor and upper
limb function, assessment of cognition and executivefunction impairments and other non-motor compo-
nents and finally evaluation of pain and sleep.
ii) At the level of activity and participation we briefly
describe the classification of functional abilities applied
to dystonia and the evaluation of mobility, abilities in
daily life activities and adaptive skills. We also include
in this section some detail outline of goal-setting and
objective evaluation of the goals.
iii) Assessment of quality of life. Even though quality of life
(QoL) is not an area that is measured by the ICF, this is
an important area to measure in childhood disability.
We acknowledge that there are also personal and contex-
tual factors to consider and these are not discussed here as the
knowledge of the influence of these factors is even less well-
understood. However we have also collected measurements
of carer burden.
Given the lack of reports using functional outcome mea-
sures across different multidisciplinary teams, this guideline
serves as a preliminary discussion point.
Table 1 summarizes the strengths and challenges of
impairment scales such as the BFMDRS and of functional
outcome measures.
2.1. At the level of body function and structures. Level of
impairment
2.1.1. Assessment of motor impairment
2.1.1.1. Dystonia severity. The BFMDRS rates dystonia
severity and was originally developed in adults with primary
dystonia though it has been applied almost systematically to
children with secondary dystonia including dyskinetic CP and
heredodegenerative conditions such as PANK-2 disorders.
There have been several reports exploring the sensitivity of
this measure by comparing the results with othermeasures of
activity and participation70e72 and goal attainment using the
Canadian occupational performance measure (COPM)70 and
goal attainment scale (GAS).72 Results in secondary dystonia
show improvement in goal acquisition despite little change in
dystonia severity as measured by the BFMDRS, partly because
the scale magnifies the benefit of small changes to dystonia at
themild end of the dystonia spectrum compared to the severe
end. For instance a 10 point change to someone with a base-
line BFMDRS of 20 results in a 50% improvement in dystonia.
On the other hand, a 10-point change in BFMDRS to someone
with a baseline of 100 gives only a 10% change. This has lead to
the question: ‘to whom does a 10-point change in BFMDRS
mattermost?’Anotherway of looking at this is to consider the
idea of ‘Functional Residual Capacity” defined as [maximum
BFMDRS-baseline BFMDRS]. Using this, a mildly affected
subject with a baseline BFMDRS of 20-points retains a large
amount of “Functional Residual Capacity” which does not
change much after a 10-point change. However, the subject
with a baseline BFMDRS of 100 experiences a functional ca-
pacity gain of 50% after a 10-point drop in BFMDRS. Such
considerations are leading to the use of absolute rather than
relative changes in BFMDRS scores respectively.
Further, preliminary analysis of the results using a blind-
rated standardised outcome measure, the assessment of
motor and process skills (AMPS),45 are promising in showing
Table 1 e Challenges and strengths of functional outcome measures vs the BurkeeFahnMarsden Dystonia Rating Scale.
BFMDRS e Strengths Functional outcomes e Strengths
Wide-spread use as a DBS outcome measure Intended for use in a paediatric (þ/ adult) population.
Systematic and structured evaluation Measure skills relevant to daily life
Proven validity and reliability in adult primary dystonia More likely to measure items that are meaningful to children and carers
No expensive resources required e relative ease of use Useful tools to inform realistic goal setting
Can be scored by a range of professionals Adds to understanding of impact of DBS on function and daily life
Allows analysis of outcomes related to specific items Proven reliability
Numerical result allows comparison over time within
and between subjects
Numerical result allows comparison over time within and between
subjects
Can be used in both paediatric and adult cases allowing
continued use after transition.
BFMDRS e Challenges Functional outcomes e Challenges
No validation or reliability studies in paediatric population Significant clinical time required to implement and score
May require further validation for secondary dystonias Specialist skills/training required for some measures
Floor effects for more involved children Resource intensive
Scoring criteria not adequately described Discipline specific
Disability scale too crude Implementation challenges:
- Application difficult in highly disabled individuals
- Variable ability e unable to apply all measures to all cases
- Impacts on between subject cohort comparison
Scores dystonia, not function or other impairments
Non interpretive use of the movement scale may result
in high scores despite little dystonia
Functional outcome changes do not always correlate to
similar trend in BFM score
Potential moving and handling risks Not all are validated for use in dystonic movement disorders
Requires cooperation and degree of cognition Paediatric v adult measures e change in measures used at transition
Require cooperation and degree of cognition
BFMDRS: BurkeeFahneMarsden Dystonia Rating Scale, DBS: Deep brain stimulation.
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blind-rated measure of functional ability despite relatively
little BFMDRS change.22 Other impairment rating scales
including those that differentiate between dystonia and
choreoathetosis, the dyskinetic impairment scale (DIS)73
have been proposed. Until now, no interventional studies
using DIS as a primary outcome measure exist to explore the
feasibility of applying and scoring this for clinical purposes.
However, the DIS does show that the dystonia component of
the DIS contributes far more to disability that the chorea
component of the DIS.74 This may explain why BFMDRS
scores may remain elevated because of persistent chor-
eoathetosis at rest and during activity maintains an elevated
score even though the dystonic element may have dimin-
ished substantially.
Published clinical findings are mainly limited to the
neurological impairment. Given the heterogeneity of our
sample, the validation of this scale in primary adult dystonia36
or in a multicentre trial also with adult primary dystonia
(mean age 51 (SD 14.8))75 might be challenged when applied to
a group of secondary dystonias such as dyskinetic CP.
Reviewing dystonia in children in 2013, Mink highlights the
lack of a perfect dystonia rating skill that has shown sound
psychometric properties across all types of dystonia in child-
hood.76 This problem has now been partly overcome using a
‘Rosetta Stone’ method which ‘translates’ the BFMDRS
impairment scale into three functional scales commonly used
in CP classification for a group of primary, secondary
(including CP) and progressive dystonias of childhood.67 The
three functional scales have been used and validated in the
world of cerebral palsy research77 and comprise of i) the gross
motor function classification system (GMFCS),78 ii) themanualability classification system (MACS)79 and iii) the Communi-
cation Function Classification System (CFCS).80
2.1.1.2. Gross motor severity: using the GMFM. Some assess-
ments of gross motor function have been classified under the
ICF across more than one domain such as the gross motor
function measure (GMFM)37 which crosses body function and
activity domains. To our knowledge, no systematic way of
assessing the outcomes of interventions in dystonia exist
using standardised assessments of gross motor function.
Preliminary results using GMFM before and after DBS81 have
now been extended to a larger cohort of children and young
people and this work will soon be available in the academic
literature.
2.1.1.3. Upper limb severity: the QUEST and MA-2. Similarly to
the GMFM, measures of upper limb function often move
across two domains of the ICF such as impairment and ac-
tivity. This is the case for the Quality of Upper Extremity Skills
Test (QUEST)82 and the Melbourne Assessment 2 (MA-2).38
Both assessments have been used in the measurement of
the medical and surgical interventions.71,83 The MA-2
assessment, for example, was improved from the original
Melbourne upper limb assessment84 with only 1 dyskinetic CP
in the sample of children used to test psychometric properties
of this UL tool.We are currently leading a validation process of
the assessment using the MA-2 and establishing inter-rater
and intra-rater reliability for dystonia in childhood. Whilst
some established teams might have initiated measuring
upper limb function using the original Melbourne, the authors
have produced guidelines so that the scores can be extrapo-
lated and used in the updated version of MA-2. This has
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difficulties that children and young people experience given
that the MA-2 measures 4 distinct areas including: 1. Range, 2.
Accuracy, 3. Dexterity and 4. Fluency of movement (ROM)
respectively. The combination of results from MA-2 and
comparison with other outcome measures in dystonia could
prove an interesting advance in the understanding of changes
through interventions such as DBS. For example, one could
hypothesise that changes in ROM for children without con-
tractures and deformities might reflect a change in sustained
postures (dystonia) whilst changes in dexterity and fluency
might refer to a more phasic element of the disorder (rapid
dystonia, choreoathetosis or tremor).
There are other established upper limb assessments used
such as the Assisting Hand Assessment (AHA)85 or
questionnaire-based Children Hand Use Questionnaire
(CHEQ)86 but these are tools to be used with children with
unilateral involvement. Given that the highest proportion of
dyskinetic CP include children with 4-limb involvement, tools
such as AHA or CHEQ are not likely to be assessments widely
adopted in the teams evaluating interventions such as DBS or
ITB. Application of these tools to children and young people
with asymmetric bilateral upper limb involvement should not
be encouraged.
2.1.1.4. Upper limb assessment using kinematics. Advance-
ment in this area has been made in the last few years
measuring upper limb movements using kinematics by a few
groups.87e91 However, the use of kinematics in combination
with other functional assessments to evaluate intervention
outcomes is yet to be performed and kinematic impairment
variables need to be analysed using principal component
analysis to provide a ‘numerical snapshot’ for comparative
and analytic purposes and then translated into a meaningful
functional score.
2.1.1.5. Quality of movement and selective movement control.
Quality of movement can be measured using the Quality
Function Measure (QFM).92 The QFM has been applied to a
small sample of children and young people with dystonia and
other HMD93 in our centre, exploring the psychometric prop-
erties of the tool when applied to this heterogeneous group of
children. The measure might be sensitive enough to capture
changes following DBS for example. Changes in QFM could be
correlated to other measures of gross motor function such as
the GMFM as well as more functional measures across the
domain of activities and participation such as the AMPS or
Mobility assessments.
The objective assessment of selective movement control
(SMC) offers the clinician information about why a childmight
have functional difficulties, since dystonia alone might not be
the only contributor to functional difficulties. Although
assessment of SMC for the lower limb is routinely performed
using standardised assessments, uptake of the SMC assess-
ment for the upper limbs is scarce.
2.1.2. Assessment of non-motor components in dystonia
In both the cerebral palsy and the dystonia literature, the
focus on motor impairments dominate over non-motor com-
ponents such as cognition and executive function. However,there are some interesting reports and studies focussing on
non-motor factors, particularly in the adult population with
dystonia.24e26,94
2.1.2.1. Assessment of cognition. Reports have focussed on
cognitive function in children with spastic CP95 however Pueyo
and colleagues compare children with spastic and dyskinetic
CP96 albeit only a small sample of dyskinetic CP and the clas-
sification is unclear (i.e. Dyskinetic diplegia). More specifically,
there are now two relatively large sample reports for cognition
stability before and after DBS in primary childhood onset
dystonia97 and secondary paediatric dystonia98 and in a small
group of Pantothenate Kinase Associated Neurodegeneration
(PKAN) dystonia.99 Owen and colleagues (2016) report an
improvement on perceptual reasoning following DBS in sec-
ondary dystonia98 andMahoney (2011) reported improvements
in tasks with a visual content such as picture concepts; vo-
cabulary/picture vocabulary; visual immediate and delayed
memory; faces immediate and delayed memory.99 Although
these reports are promising, more work in this area is
encouraged including the elimination of possible confounding
variables and the role they might play in the improvement.
Improvements noted in cognition could be due to several fac-
tors such as i) a reduction of medication after DBS, in cases of
dystonia and other HMD, ii) improved motor ability to access
tools and materials such as reduction of a dystonic neck pull
that allows the child to keep the head in the mid-line for eye-
gaze access (an improvement that the BFMDRS is unlikely to
be sensitive enough to detect) and iii) the DBS has an inde-
pendent effect on cognition by directly influencing the
cognitive-associative basal ganglia-cortical loop.
There are certainly challenges to measure cognition in this
heterogeneous population, which comprise all levels of
GFMCS, MACS and CFCS. Some children and young people are
verbal whilst others can only communicate via eye-pointing
for example. Manual Function will have an impact on what
tests can be performed by the child and it is important that
children and young people are not penalised for their move-
ment disorder when they are attempting to access materials
and tools for cognitive assessments. Unfortunately, there is
probably no single measure that can be applied to the entire
cohort with dystonia though an attempt should we made to
assess our most severely affected children. In our group the
joint work between psychology and occupational therapy has
allowed some assessments to be completed with children and
young people that are both non-verbal and GFMCS level-V and
who only have reliable eye pointing if they are handled out
with their wheelchair (e.g. on the lap) by their parents or an
experienced therapist. We have attempted to maintain the
therapist bias-free when interpreting eye movements whilst
handling children by positioning the materials away from the
therapist so that she/he cannot see what the answers are. We
are in the process of describing in detail the practicalities of
applying this approach to enable children to access psycho-
logical testing.
2.1.2.2. Assessment of executive function. The assessment of
executive functions in childhood dystonia and their contri-
bution to the understanding of baseline characteristics/profile
has not beenwidely reported. In fact, this is an aspect that has
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although some more reports are emerging.95,100e103 The
Behaviour Rating Inventory of Executive Function (BRIEF)104 is
a parent-reported questionnaire but correlations with objec-
tive executive function scores/tests of assessments of adap-
tive skills are not yet available. Given the non-motor factors
reported in the adult dystonia literature, it seems reasonable
to measure this in childhood-related dystonia disorders.
Again, as with cognitive assessments, the heterogeneity of the
children and young people attending our service poses diffi-
culties in terms of choosing only one assessment, so a core set
of assessments should be considered depending on the
motor-capacity of the child.We propose that these core sets of
assessments are grouped not only on verbal or non-verbal
capacity but also in relation to MACS and CFCS levels as
they might serve as indicators of access-limitation to mate-
rials (many requiring manual function to use pen and paper).
Motor-planning defines how a motor goal will be ach-
ieved.105 Steenbergen and colleagues have investigated
motor-planning deficits in congenital hemiplegia as a possible
underlying reason for difficulties in activities of daily living
(ADL).106,107 Others have also investigated motor-planning
ability in children with unilateral involvement106,108,109 and
concluded that there was no relationship with functional
ability though the latter was only measured by a question-
naire. These studies have been performed in spastic unilateral
cerebral palsy. Although clinically many of the same issues
might be presentwhen assessing ADLs performed in dystonia,
the pathophysiology of unilateral spastic CP and dystonic CP
(or any other dystonia) is very different. In fact, the same
group of authors recommend future rehabilitation efforts to
be guided by treatment efficacy with specific pathophysi-
ology.110 In our experience, there seems to be a significant
element ofmotor planningwhich influences a child's ability to
performADLs but clearly the pathophysiologywill be different
to current available studies and we urge caution using rec-
ommendations taken from studies of spastic CP. A very recent
report by Kukke and colleagues (2016) studied 11 childrenwith
hemidystonia (and some spasticity) using kinematics and
concluded that the reduced coordination during movement
could reflect deficits in motor planning.87 The possibility of
visuospatial orientation (mental rotation) abnormalities in
dystonic children also require evaluation when interpreting
processing skills in dystonia.
2.1.2.3. Assessment of anxiety. Reported in the adult primary
dystonia literature,94 anxiety is a common feature observed in
children and young people with dystonia attending our
clinics. With some limited evidence on behavioural in-
terventions in primary dystonia23 there are currently no
studies available in childhood dystonia.
2.1.2.4. Assessment of pain. Pain is one of themost frequently
reported areas of concerns by young people with dystonia and
their families5,34 and improvements in dystonia pain have
been recently reported with gabapentin.68 Pain is also a
frequently reported concern for children with CP.111e113
Reduction of pain is possible with DBS even though signifi-
cant changes might not be captured in terms of dystonia
reduction.72 There are several pain assessments in use butagain, the use of only one assessment for all children and
young people might prove difficult as some need the child to
directly respond either verbally or using eye pointing (VAS)114
and others might need to be used as a proxy measure by
parents if the child is non-verbal or either too young or
cognitively not able to provide a reliable answer such as the
paediatric pain profile (PPP).44 As pain reduction has been one
of the most frequent goals identified by young people and
their families in our cohort,5,34 we have been able to use the
COPM to measure changes in pain affecting daily life. The
COPM can be used with all children and young people and
their families and may be used to rate pain if this is a goal for
intervention and it affects any day-to-day activities. More in-
formation is detailed in the goal-setting section below.
2.1.2.5. Assessment of sleep. Sleep forms an essential
component of health and well-being and is characteristically
fragmented throughout life in children with dystonia. The
Dystonia Severity Assessment Plan (DSAP: ‘dystonia soon as
possible’)115,116 is based on two critical observations of well-
being in dystonia of childhood: the ability to sit comfortably
and sleep well at night (DSAP grade 1). Poor sitting tolerance
but preserved sleep quality and quantity lowers the DSAP to
grade 2. An inability to sit comfortably or sleep at night con-
stitutes the need for urgent clinical review: DSAP grade 3 and
may herald the rapid deterioration to metabolic decompen-
sation (DSAP grade 4) and status dystonicus (DSAP grade 5) in
short order. We have begun to use the DSAP to monitor the
progress of children with severe, often brittle dystonia and
measure improvements after gabapentin68 along with the ICF
domain on sleep: ‘Amount of sleep’ (B1340): ‘Maintenance of
sleep’ (B1342) graded 0e4 where 0 ¼ no impairment/difficulty;
1 ¼ Mild impairment/difficulty (present<25% of the time, in-
tensity is tolerable, rare); 2 ¼ Moderate impairment/difficulty
(present <50% of the time, intensity is interfering in day-to-
day life, occasional); 3 ¼ Severe impairment/difficulty (pre-
sent >50% of the time, intensity partially disruptive, often);
4¼ Complete impairment/difficulty (present >95% of the time,
intensity totally disruptive, constant); 8 ¼ Not specified
(insufficient information); 9 ¼ Not applicable.
Such assessments of sleep are important because of the
beneficial impact of sleep in ‘switching off dystonia and
chorea’.117e119
2.1.3. At the levels of activity and participation
2.1.3.1. Classification of function. Well-established classifica-
tions of functional ability for gross motor (GMFCS) and
manual function (MACS) are being used in studies of cerebral
palsy. The use of these classifications in childhood dystonia
studies (even when including dyskinetic CP) is less usual. We
recently looked at the use of these two classification systems
and included a more recent one classifying communication
(CFCS) with childhood dystonia (both dyskinetic CP and other
forms of childhood dystonia and other HMD) using a ‘Rosetta
Stone’ approach, i.e. correlating the BFMDRS with the three
motor function scales.67 The correlations between GMFCS
and BFMDRS showed a clear linear relationship indicating
almost equal blocks of 20e25 BFMDRS points between each of
the GFMCS levels. It could be argued that even for studies that
are not describing the GMFCS levels, one could take the
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how functionally impaired the children in those studies
might have been. Although correlations were high, the rela-
tionship between MACS and CFCS with the BFMDRS did not
show such a clear linear relationship in the milder categories
I, II and III, possibly indicating that a child's ability to access
communication and to perform ADLs is not purely down to
motor but also that non-motor factors such as cognition or
planning might have an important role. We recommend a
minimal dataset for future studies to classify children and
young people using these free, easy and quickly applied
functional classifications so that comparison between pop-
ulations and cohorts from different studies is possible.
2.1.3.2. Evaluation of abilities in daily life activities, adaptive
skills. Since the literature is predominantly concerned with
the domains of body structure and function, there is limited
understanding of either functional characteristics of children
and young people with dystonia and other HMD or of in-
terventions to improve areas of daily life activities or ‘adaptive
skills’.5
‘Adaptive skill's or ‘adaptive behaviour’ include age-
appropriate skills necessary to live independently. Often
measured with questionnaires such as the Pediatric Evaluation
Disability Inventory Computer Adaptive Test (PEDI-CAT),120 the
Vineland Adaptive Behaviour Scales (Vineland-II)121 or the
Adaptive Behaviour Assessment System (ABAS-II).122 In child-
hood onset dystonia and other HMD, the use of these assess-
ments has not yet been formally used. In one study using the
PEDI, €Ohrvall and colleagues explored the relationship between
self-care andmobility skills and theMACS levels. Theysuggesta
clear tendency for functional skills to increase with age and
discuss the age at which different MACS levels are likely to
achieve top scoreson the PEDI. At age 9with aMACS I and at age
12with aMACS II compared to typical developing children aged
6 years 6months.123 These recommendationswhilst useful as a
potentialpredictormightnotholdwhenapplied tochildrenwith
dystoniaotherHMDincludingdyskineticCP. For example, in the
above study, the children with dyskinetic CP were all classified
MACS IIIeV. Caution therefore should be taken when applying
research results that aremainly based on spastic CP to children
and young people with dyskinetic CP. The use of this relatively
inexpensive assessment across different centres, together with
MACS and GMFCS classifications could provide us with large
enough numbers to explore the relationship between these
classifications systems and the PEDI-CAT.
An objective assessment that focuses on activities of daily
living is the Assessment of Motor and Process Skills (AMPS).45
Better understanding of motor and non-motor baseline char-
acteristics of children and young people with HMD would aid
us in developing more targeted interventions in our cohort of
children. Preliminary evidence using AMPS pre- and post-DBS
is available.22
One issue remains in finding an appropriate outcome
measure that could be applied to such a heterogeneous pop-
ulation with different levels of motor severity, pathophysi-
ology and functional ability. However, given that the focus
and priorities of children and young people and their families
revolve around every day activities, there is a need for
measuring outcomes around this domain.Our assessment process includes a repertoire of imaging
and medical testing but goes beyond the impairment level (as
outlined in the WHO ICF framework) and also assesses other
areas that could influence the child/young person's ability to
participate fully in all activities of daily living and in the
community.
The extent to which outcome measures generate future
goals will be explored.
2.1.4. Goal-setting in dystonia
Finding out the real priorities and concerns for young people
withmovement disorders such as dystonia, particularly those
that undergo DBS, will enhance our knowledge of what is
really important for these young people and how we can help
address those areas of concern and need. Tools, such as the
Canadian Occupational Performance Measure (COPM)51 and
the Goal Attainment Scale (GAS),52 directly identify and
measure client/carer concerns and the extent to which the
intervention has led to meaningful change in these areas.
These tools provide a meaningful way of measuring how well
we are able to pre-operatively predict an individual's response
to DBS, which is useful in informing future client selection, as
well as identifying goal areas more likely to be responsive to
the intervention. Such a model is applicable to a range of in-
terventions and is widespread in paediatric practice, which
we consider an essential benchmark for the delivery of a com-
plex motor disorder service for children and young people
offering invasive interventions such as DBS.
The implementationof formal goal-setting forDBS therapy,
using the COPM, over a period of some years has made it
possible for our service's therapists to counsel parents about
DBS results based on therapist experience with a cohort of
more than 130 children implanted since 2007. For instance, our
accumulated experience indicates frequently positive out-
comes with regards to pain and comfort but typically little
response in terms of speech intelligibility in children with
secondary dystonia.
There have been a number of challenges to embedding
current goal-setting practice. Occupational therapists and
physiotherapists need to comprehensively evaluate the child
in order to determine the primary impairments contributing
to the functional difficulties and the extent to which the
intervention (DBS) may address these. For example, impair-
ments commonly seen in association with dystonia in our
patient group include hypotonia, reduced selective motor
control, contracture and deformity, and planning and organ-
isational difficulties, yet DBS would not directly address all
these aspects, except in the sense that dystonia comprises
both hypertonia and hypotonia i.e. both extremes of tone and
posture range and DBS stabilises the lurching of the motor
system from one extreme to another. The possibility of fluc-
tuating mood, behaviour or even cognitive functions in dys-
tonia in childhood requires further exploration. The challenge
is to identify which areas may reasonably be expected to
improve should DBS successfully ameliorate involuntary
postures and movements and how those will influence func-
tion and participation.We have found it useful to defer formal
goal-setting until the end of the assessment process, allowing
a more comprehensive picture to be built-up between family
and allied health professionals regarding the factors
e u r o p e a n j o u r n a l o f p a e d i a t r i c n e u r o l o g y 2 1 ( 2 0 1 7 ) 1 4 7e1 6 7160contributing to the child's functional difficulties and a good
rapport has been established to allow for honest, open dis-
cussions about expectations on both sides.
Parents and carers will often identify an impairment area
and need prompting to identify the related functional diffi-
culty. For example, a parent may initially state that their goal
would be for their child to move less, while with prompting
may identify that reducing involuntary movements would
allow their child to be safely placed on an adapted toilet seat
for toileting or to safely spend leisure time on the sofa with
siblings. In this way, the aim is to demonstrate the extent to
which reduction in dystonia and dyskinesia through neuro-
modulation positively improves day-to-day activities the child
and family identify as important. Describing a specific func-
tional concern is also easier to quantify than the subjective
reporting of improvement or deterioration in involuntary
movements.
In practice, it can be time consuming to formally document
goals and agreemeans by which progress in goal-areas will be
measured. This is particularly an issue at the initial goal-
setting episode, as the pre-operative semi-structured COPM
interview may typically take an hour or more, albeit with
substantial variations. We think this time is fully justified and
manageable given the importance in capturing ‘what matters
most’ and what would constitute an improvement, before
proceeding to DBS implantation.
Follow-up evaluations are less time consuming. We have
found the clear qualitative descriptions of areas of concern
can serve as very useful prompts during feedback and as
useful reminders of a child's state some time previously when
parental recall may not be reliable. For example, when asked
how an area such as sleep has changed, a parent may say the
situation is unchanged, yet the child may be described as now
waking only once a night for a drink in contrast to parents
being up 5e6 times a night for protracted periods due to
painful dystonic spasms. In this way, the goal-setting process
helps both families and professionals to remain focused on
the areas that were identified as concerns prior to surgery
providing clarity on the extent to which meaningful progress
has been made.
We have noted cultural, emotional and personality in-
fluences in the COPM scoring process. For example, a parent
may describe an area presenting significant care difficulty and
rate poor performance for this concern, but not overtly ex-
press dissatisfaction with the problems they experience as
they consider it their “duty” to meet their child's needs.
Goal-setting in progressive neurodegenerative disorders,
such as pantothenate kinase neurodegeneration (PKAN), has
proven particularly challenging and formal goal-setting tools
such as the COPMmay not be appropriate in all cases. In these
conditions, positive progress may be only briefly achieved for
1e2 years, but stability or a change in the rate (profile) of
deterioration may represent successful intervention. Further,
with time, the inevitable and inexorable deterioration can
make it difficult to ascertain the extent to which DBS is
significantly ameliorating the child's movement disorder and
improving the child's quality of life. We have had experience
in some PKAN cases, where the young person has rapidly gone
into status dystonicus following inadvertent de-activation of
the DBS, which resolved quickly with reactivation. Suchexperiences have highlighted to both families and clinicians
the extent to which DBS may be positively contributing to a
child's management, despite the persistent and severe dys-
tonia, whichmay be present when the DBS is active. Clearly, it
would not be ethical, nor desirable, to inactivate DBS to eval-
uate efficacy, particularly given concerns of precipitating
status dystonicus as a rebound phenomenon following DBS
cessation.115
2.1.4.1. Objective and blind rating evaluation of goals
2.1.4.1.1. PQRS. As Mink (2013) points out, movement
disorders in childhood are a heterogeneous group and there
are challenges not only with definition of their diagnosis but
also with assessment and treatment (management) across
different aetiological background, motor severity and age.76
As with other populations, the use of goal-setting has been
proven possible and sensitive to capture change following
surgical interventions70,124 but one argument would be that
goal-acquisition reporting with tools such as the COPM is a
self-reported outcome and therefore lacks the objectivity that
many claim necessary for the systematic evaluation of inter-
ventional outcomes.With the challenges of applying the same
assessment across this heterogeneous population, the use of
client-centred and client-chosen goals is promising. The
objective evaluation of those goals is possible and has been
tested in studies using a specific intervention named cognitive
orientation to daily occupational performance (CO-OP).125e128
Using the Performance Quality Rating Scale (PQRS)46 it is
indeed possible to objectively measure client-selected func-
tional goals. A study validating the use of PQRS for dystonia
and other HMD is currently in progress.129 This is a promising
tool that would allow a systematic study of objective mea-
surement of goal acquisition and comparison with self-rated
goals from the children and families perspective. It could be
used across any age, GMFCS, MACS or CFCS level and across
any aetiological background.
2.1.5. Assessment of quality of life
Quality of life (QoL) is not yet included in the ICF and is often
considered separately. Often used as an outcome for research
studies in cerebral palsy130 and in adult movement disorders.
In childhood dystonia, Eggink et al., 2014 recently reported the
health related quality of life (HRQOL) in rare inborn errors of
metabolism with movement disorders.131 QoL is self-reported
and it can be used towards studying health economics cal-
culations. HRQOL questionnaires are self-reported and can be
easy and quick to administer. Cost effectiveness of a study can
therefore be calculated using cost per quality-adjusted life
years (QALYs) where possible. For example, the EQ-5D-5L132 is
a generic, preference based, HRQOL that has 3 versions,
making it possible to apply independently of the age; EQ-5D-Y
(for children under the age of 12), EQ-5D-3L (for young people
aged 12e18) and EQ-5D-5L (for young adults and adults).
2.2. Can we learn from studies of dystonia in adults or
from studies of CP?
When evaluating treatment interventions with childhood
onset dystonia and other HMD, the evidence other than
pharmacological or neurosurgical is scarce and disappointing.
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surgical interventions that were classified as green (meaning
that there was enough and strong evidence to support such
interventions in CP), mostly applied to children and young
people with spastic CP, the majority unilateral (spastic) CP.69
When reviewing the studies mentioned in Novak's system-
atic review on bimanual training, constrained induced
movement therapy, context-focused therapy and goal-
directed training, all studies either mentioned that the inclu-
sion criteria was spastic CP or did not mention whether they
included dyskinetic CP, nor did they analyse this subgroup of
patients separately. Only one study for goal-directed training
(home programmes) by Novak et al., 2009 included 5 children
with dyskinetic CP from a total of n ¼ 36.133 Whilst this is
encouraging, the study had 3 arms for intervention (i) 8 week
occupational therapy home programme (OTHP), ii) 4 weeks
OTHP and iii) No OTHP). Due to the small number of dyskinetic
CP, randomisation only took place to the 4week OTHP and no
OTHP and no children with dyskinetic CP in the 8 week OTHP.
We acknowledge that stratifying by phenotype would have
been difficult with such small percentage of children and
young people with dyskinetic CP.
This is also the case for childhood stroke and as Ganesan
(2013) points out, current rehab approaches are rarely
evidence-based and based usually on children with spastic
CP.134 Ganesan urges rehab approaches to focus on the pattern
of impairment rather than diagnosis, for example dystonia
rather than spasticity, which is more likely after arterial
ischaemic stroke in children. Yet again, most stroke rehabili-
tation approaches target spasticity. The literature on hemi-
paresis following perinatal stroke is altogether different, partly
based on early recognition it has been possible to develop
population-based interventional studies of CIMT and HABIT
alone or combined with transcutaneous Direct Current Stim-
ulation (tDCS) in the state of Alberta, Canada, and this clinical-
epidemiological/population-developmental neurobiological
multidisciplinary model, along with the background scientific
literature has been extensively reviewed by Adam Kirton.135
A subsequent literature search was performed using the
terms ‘dystonia’ OR ‘hyperkinetic movement disorders’ OR
‘athetosis’ OR ‘dyskinetic cerebral palsy’ AND ‘rehabilitation’
OR ‘occupational therapy’OR ‘physiotherapy’OR ‘goal-oriented
intervention’ OR ‘behavioural intervention’ AND ‘children’ OR
‘childhood’ in order to capture any results from interventions
since the published systematic review of systematic reviews by
Novak et al. 2013.69 The results did not show any other pattern
in terms of the available reports, mainly including studies
developed for inclusion of children with spastic CP.
Despite the absence of clear evidence supporting their use,
some authors report on the desirability of frequent of physio-
therapy and occupational therapy sessions to be delivered136
though this is not based in actual evidence-supported
studies. A recent review paper on current and emerging stra-
tegies for children with dystonia outlines current intervention
strategies, though these again are not based on evidence.91
2.2.1. Is there a role for biofeedback interventions in childhood
dystonia?
Biofeedback in childhood dystonia may be volunteered as
useful for learning though this is not based on learning forevery day activities and it relates purely to lab based learning
studies.87,91 Interestingly the authors make an assumption
that sensoriomotor impairments in childhood dystonia
hamper acquisition and consolidation of gross and fine motor
skills crucial for cognitive and social development. However, it
could be debated that these paradigms have not yet been
tested since very few if any studies look at the relationship
between sensoriomotor impairments and acquisition and
consolidation of such impairments.
Casellato and colleagues describe two studies in 2012 and
2013137,138 exclusively with children with primary dystonia to
improve motor control with EMG-based visual-haptic
biofeedback137 and with error enhancing robot therapy.138
Again, reporting only at the impairment level makes any
generalisation to real life situations doubtfully meaningful
and conclusions cannot be drawn on whether those changes
are in fact clinically significant for the child/young person or
in terms of their ability to learn new activities. In our experi-
ence, children with primary dystonia continue to have diffi-
culties with day-to-day activities even when dystonia severity
is reduced significantly22 given their non-motor co-morbid-
ities. Therefore motor-learning based approaches might have
to include elements beyond sensoriomotor rehabilitation or
robot generated deviating forces.
2.2.2. Ongoing registered trials on childhood dystonia
On a review of the International Standard Randomised
Controlled Trials Number Registry (ISRCTN) we only found 1
study currently in progress. The study is led by the first author
of thismanuscript (Gimeno, H) and registered ISRCTN57997252
investigating the role of a cognitive-based approach in child-
hood onset and other HMD using two consecutive series of N-
of-1 trials.139 We are aware of one other pilot study using eye
gaze technology with young children with dyskinetic CP but
this is not registered and is currently underway (personal
communication with Petra Karlsoon, June 2016).
Recommendations for future research are outlined in the
last section of this manuscript with proposals about potential
designs to improve our understanding and knowledge of
childhood dystonia and outcomes.3. Recommendations for multi-centre
collaboration in regards to functional clinical
outcomes and future research methods
Primary and secondary dystonia might havemore in common
than comparisons or extrapolated recommendations from
spastic CP studies to dystonia. This follows the saying: ‘dys-
tonia, is dystonia, is dystonia’ regardless of aetiology, so the
important strategy is to build on existing models of dystonia.
Given the progress with genetics (see Silveira-Moryama and
Lin 2015 for further discussion)9 children with a diagnosis of CP
may later on be diagnosed with genetic diagnoses such as
dopa-responsive dystonia (DRD), other monogenetic dysto-
nias such as benign hereditary chorea or even an NBIA9 but
new genes, possibly more common than those currently re-
ported are also emerging so we should therefore develop in-
terventions that can work across different aetiological groups
in dystonia and other HMD, looking at shared features
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as timing of onset and the impact of the proportion of life lived
with dystonia at a time-critical period of early motor
development.65
We propose below some points to initiate discussion and
suggestions for future collaboration.
3.1. Suggestions for the future
1. Validation of outcome measures:
Having a non-homogeneous group of young people pre-
sents challenges throughout any management strategy
implementation such as DBS neuromodulation. Given the
limited psychometric testing in well-known outcome mea-
sures in CP, which have been mainly tested in spastic CP, we
urge caution when applied to childhood dystonia and other
HMD.
Ideally, collaborative work between centres that have
experience in applying outcome measures with dystonia
should be a priority in terms of validating these measures.
This requires incorporation of allied health professionals as
core members of the multidisciplinary team.
2. Allied health professionals embedded in multidisciplinary
teams:
It is our impression that there are limited clinical services
with bespoke multidisciplinary team approaches to assess-
ment and management of children with movement disorders
and this might be a reason for a lack of reports addressing
domains of the ICF beyond impairment. Hence, our limited
knowledge about effective interventions in domains of activ-
ity and participation in the paediatric population, particularly
secondary dystonias. It will therefore be difficult to anticipate
possible outcomes and establish realistic goals with young
people and families. We would encourage multidisciplinary
teams to include not only physiotherapy but also occupational
therapy, speech and language therapy and psychology col-
leagues. One proposal will be to join forces in describing goal-
acquisition with current available studies in DBS and ITB
measured with COPM and GAS. We acknowledge that intense
training and work across disciplines in the initial period with
professionals working often outside their specific therapy/
medical roles will be needed. Ideally, a training package
agreed by international consensus (including AHPs) might be
a way forward.
3. Applying dystonia severity scales:
Most often international teams focus on impairment with
use of dystonia rating scales, which is undoubtedly an
important area to describe. Given the heterogeneity of our
groups and the difficulties applying a well-established and
internationally used outcomemeasure such as the BFMDRS to
a population with severe disability (above 100 out of 120 in
BFMDRS) we propose, as a minimum, that studies report not
only a dystonia severity scale but also functional ability clas-
sification systems, the GMFCS at a minimum but ideally
together with the MACS and CFCS.4. Capturing the variability in dystonia:
Variability of performance is characteristic in childhood
dystonia and other HMD. Often described as variability within
the same hour, day or week, the importance of multiple
baselines before intervention may be warranted in this pop-
ulation. Randomised controlled trials, though considered the
gold standard,might not be appropriate for these children and
young people as a single data point before and after inter-
vention will fail to capture real life performance (i.e. Vari-
ability). A potential goal for intervention could be in fact to
reduce such a prominent variability, so that performance be-
comes more stable which in turn might give children and
young people more confidence to try new things.
5. Research design in childhood dystonia and other HMD:
We have outlined the limited evidence and research in
childhood dystonia. Mink 2013 highlights how most dystonia
‘treatments’ are designed for and tested in primary dystonia
and the ability to generalize these findings for dyskinetic CP or
any other form of secondary dystonia is limited.76 We agree
that there continues to be an increasing need for further
experimental therapeutic research in this population.
Recommendations to consider methodological ap-
proaches using proof of principle and pilot studies to allow
for subsequent well-designed randomised, controlled trials,
and long-term observational trials have been made.6,76,140
The use of single-case experimental design or N-of-1 trials
using multiple replications across subjects could offer an
answer to some of the problems with variability and meth-
odological issues.4. Conclusions
We present a comprehensive scheme for approaching move-
ment disorders in children, including dystonia and chor-
eoathetosis of necessity originating from many disparate
aetiologies. Searching for common themes has helped us as a
clinical group, to define core issues relating to refinement of
the phenotype with neurophysiological,62,141 radiolog-
ical63,142,143 and functional metabolic144 assessments respec-
tively. These approaches help us understand the physiological
context of dystonia and contribute to patient-selection for
DBS and also allow interpretation of outcomes, which further
refines the selection iteration process. Goal-focussed practices
confer an understanding of meaningful outcomes, which in
turn result in contented children and families. However past
goals must be replaced by future objectives. The dynamic
needs of the child, young person, families and carers consti-
tutes the need to incorporate ‘resilient’ assessments, and
perhaps more importantly resilient perspectives among
referring and treating clinicians, children, young people, de-
vice manufacturers and the health-care providers. Neuro-
modulation for dystonia in children is now at last becoming
accepted as a rich, legitimate field of clinical practice which
demands as never before a multidisciplinary clinical-research
approach to drive our clinical models towards desirable
‘virtuous outcome spirals’ in which each iteration leads to
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other contributions to this special edition on Advances in
Neuromodulation in Children indicate that although there are
no ‘quick fixes’ the prospect for lasting meaningful benefits in
chronic, disabling dystonias of childhood are a tangible re-
ality. The challenges of patient stratification for precision
medicine-in this case functional neuromodulation
neurosurgery-must be grasped wisely.
The lack of studies in childhood dystonia across any
intervention other than pharmacological or neurosurgical
approaches, which themselves often fail to capture what
mattersmost to children and their carers,5 calls for immediate
action from the clinical-scientific community to generate new
knowledge on interventions that might be possible with this
group of patients. This might require a paradigm shift and the
application of knowledge of motor control andmotor learning
theories, together with learning and cognitive paradigms to
improve outcomes for children and young people with dys-
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